
LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms
Keywords: Clinical outcomes; Endovascular embolization; Enterprise stents; Intracranial aneurysms; LVIS stentsAA, Arachidonic acid; ADP, Adenosine diphosphate; mRS, Modified Rankin Score; TIA, Transient ischemic attack